CareStart™ Covid-19 Antigen
The CareStart™ COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted nucleocapsid protein antigens specific to SARS-CoV-2 in anterior nares swab specimens directly collected from symptomatic individuals who are suspected of COVID-19 by their healthcare provider.
Detect active infection status in 10 minutes.
No lab equipment or additional instrument required.
EASY TO USE
Lower nasal swab collection enables comfortable specimen collection.
Manufactured in the USA
Manufactured in the U.S. by a U.S. headquartered company
Point-Of-Care (POC) Designated Test
As an intended point-of-care (POC) designated test performed by medical professionals with a 10 minutes processing time, CareStart™ COVID-19 Antigen Test helps provide critical answers about active infections to patients and healthcare workers alike.
Bloomberg: FDA Approval for CareStart™
Reeve Benaron, chairman and interim chief executive officer at Intrivo, discusses the U.S. Food and Drug Administration’s emergency use authorization of a Covid-19 antigen test the company distributes for Access Bio. Benaron speaks with Bloomberg’s Emily Chang. (Source: Bloomberg)
Reagents & Materials Provided
Kit Component / Amount Per Kit
Test Devices / 20 ct.
Assay buffer / 20 ct.
Extraction vials and caps / 20 ct.
Specimen collection swabs / 20 ct.
1 Positive and 1 Negative control swab
Instructions for Use / 1 ct.